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Preparative chiral chromatography has become an attractive technology, used to obtain single enantiomeric 
drugs in the biotechnology, fine chemical products and pharmaceutical industries. Due to the development of 
new and more efficient modes of operation, chiral liquid chromatography using the simulated moving bed 
(SMB) technology has gained a renewed interest. The chiral separation process is a complex task, govemed by 
several different interactions between the chiral solutes, the solvent and the chiral stationary phase (CSP). In a 
preparative point of view, and when considering the choice of the mobile phase (solvent) composition, a high 
selectivity ofthe enantiomers should not be the only goal to be aimed, as it is frequently followed at analytical 
scale. Besides the choice of a CSP with highloading capacity, a high solubility ofthe solutes in the solvent and 
low retention times should a1so be taken into account~ in arder to improve the preparative process 
performance.This work will present and discuss the experimental and simulation results obtained for lhe 
analytical and preparative separation of the four stereoisomers of nadolol, an important ex.mple of a 
non-selective beta-adrenergic receptor .ntagonist «(3-blocker) pharmaceutical drog, widely used in the tre.tment 
of cardiovascular syslem diseases, such as hypertension, ischemic heart disease (angina pectoris), congestive 
heart failore and certain arrhythmias. The main focus will be placed in the selection of the proper CSP/solvent 
combinatlon for 5MB operation. Experimental result, will be presented using Chiralpak AD and Chiralpak IA 
CSP (Daicel, Europe) and different mixtures of alk.nes, .Icohols and acetonitrile as solvent. 
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